D'Amico D J, Talamo J H, Felsenstein D, Hirsch M S, Albert D M, Schooley R T
Arch Ophthalmol. 1986 Dec;104(12):1788-93. doi: 10.1001/archopht.1986.01050240062041.
Recent reports have suggested a role for BW-B759U in the treatment of cytomegalovirus retinitis. The present study presents the ophthalmoscopic features in three treated patients, and examines the microscopic findings in the eyes of the first patient ever treated with BW-B759U for cytomegalovirus retinitis. Ophthalmoscopic findings of improvement on drug therapy included remission of perivascular infiltration, stabilization of the extent of the retinal area involved, and development of a pigmented chorioretinal scar in the involved area. Relapses occurred with cessation of therapy, and repeated courses of therapy were required. One patient developed a rhegmatogenous detachment with retinal breaks in an atrophic area of treated retinitis. Electron microscopic examination of the eyes of one patient disclosed the persistence of cytomegalovirus inclusions in retinal cells despite previous drug therapy. These findings suggest a virostatic action for BW-B759U.
最近的报告表明BW - B759U在治疗巨细胞病毒性视网膜炎中发挥作用。本研究呈现了3例接受治疗患者的眼底镜检查特征,并对首例接受BW - B759U治疗巨细胞病毒性视网膜炎患者的眼部进行了显微镜检查。药物治疗后眼底镜检查显示改善的表现包括血管周围浸润消退、受累视网膜区域范围稳定以及受累区域出现色素性脉络膜视网膜瘢痕。治疗停止后出现复发,需要重复疗程。1例患者在接受治疗的视网膜炎萎缩区域出现视网膜裂孔性视网膜脱离。对1例患者眼部进行电子显微镜检查发现,尽管之前进行了药物治疗,但视网膜细胞中仍存在巨细胞病毒包涵体。这些发现提示BW - B759U具有抑制病毒的作用。